News

Researchers found that apple peels from local and commercial varieties are rich in phenolic compounds with antioxidant and antidiabetic properties. The local cultivar Amarilla de Octubre showed ...
Google DeepMind has released an improved version of its biology prediction tool, AlphaFold, that can predict the structures not only of proteins but of nearly all the elements of biological life ...
1. Noronha V, Patil V, Menon N, et al. Gefitinib vs gefitinib plus pemetrexed and carboplatin chemotherapy in EGFR -variant lung cancer—long-term results of a randomized clinical trial. JAMA Oncol.
Median OS was 17.6 months in the gefitinib group vs 27.5 months in the gefitinib plus chemotherapy group (p< .001). The 5-year OS was 4.42% in the gefitinib group vs 13.04% in the gefitinib plus ...
Yi-Long Wu, Qing Zhou, Jie Wang, et al. Randomized phase 3 study of first-line AZD3759 (zorifertinib) versus gefitinib or erlotinib in EGFR-mutant (EGFRm+) non–small-cell lung cancer (NSCLC ...
Study: Evaluation of antiviral drugs against newly emerged SARS-CoV-2 Omicron subvariants. Image Credit: Shidlovski/Shutterstock.com This news article was a review of a preliminary scientific ...
Tepotinib plus gefitinib led to improvements in progression-free survival and overall survival in patients with EGFR-mutant non–small cell lung cancer.
Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated EGFR The following represents disclosure information provided by authors of ...